Examining Experiences of Federal Offenders on Opioid Agonist Treatment (OAT) During Release from Incarceration in Ontario, Canada: A Post-Release Report (English, HTML)

View metadata and access the original English HTML file: Examining Experiences of Federal Offenders on Opioid Agonist Treatment (OAT) During Release from Incarceration in Ontario, Canada: A Post-Release Report.

Format

HTML

Access

file-only

Publisher-reported update

2025-05-05

Correctional populations experience high levels of opioid use disorder (OUD) and increased risks for related harms upon the high-risk period of community release and reintegration, including overdose and premature mortality. Opioid agonist therapy (OAT) is an effective treatment for OUD and its provision is associated with a reduction in these and other related risks during the community transition period.Please note that this report is a one page summary. If you wish to have a copy of the full report, please send a request comment via the Open Government Portal or email the OG team: opengovernmentgen-nhq@csc-scc.gc.ca.

Access original file